Sigrid Therapeutics
Quotes
Share:
Subscribe:

Tore Bengtsson founder headshot

Tue, Jul 30, 2024 08:30 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Sigrid Therapeutics Surpasses the 50% Enrollment Milestone in its Clinical Trial, SHINE, to Evaluate the SiPore21® Gel for Sustained Diabetes and Obesity Control Tue, Apr 30, 2024 08:30 CET

Sigrid Therapeutics announces appointment of distinguished Professor Iain Chapple to Scientific Advisory Board Tue, May 09, 2023 08:30 CET

Sigrid Therapeutics unveils SiPore® plaque blocker at IDS 2023 Tue, Mar 14, 2023 08:30 CET